Christopher Nash

Chatterjee Management Co (Chatterjee Management) is a private equity subsidiary of The Chatterjee Group founded in 1989 by Purnandu Chatterjee. The firm is headquartered in New York with additional offices in Bombay, Delhi and Calcutta.

Bacterin International, Inc. manufactured drug delivery coating platforms for medical devices. It was a tissue bank and medical device company that designs, processes, manufactures, and markets advanced medical products. The firm’s designs focused on efficacy and safety for the patient, and functionality and ease of use for the surgeon to fulfill niche needs in the industry. The company was founded by Guy S. Cook in 1997 and is headquartered in Belgrade, MT.

ACI Capital Co. LLC (ACI Capital) is a private equity subsidiary of Ingleside Investors LLC founded in 1995 by Kevin S. Penn. The firm is headquartered in New York.

Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ.

Cerberus Capital Management LP (Cerberus) is a private equity firm founded in 1992 by Stephen A. Feinberg and William L. Richter. It is headquartered in New York.

FMR LLC engages in the provision of financial and investment services. It offers financial planning and advice, wealth management, retirement plans, trading and brokerage services, and investment products. The company was founded by Edward C. Johnson II in 1946 and is headquartered in Boston, MA.

Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences.